Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darell D Bigner

Showing results (51-60 of 242) with videos related to

Pageof 25
Sort By:
Clinical Medicine. Oncology|September 25, 2009
Glioblastoma Multiforme Oncogenomics and Signaling PathwaysOkezie O Kanu, Betsy Hughes, Chunhui Di, et al.
Expert Opinion on Investigational Drugs|June 27, 2009
Glioblastoma multiforme: a review of where we have been and where we are goingCory Adamson, Okezie O Kanu, Ankit I Mehta, et al.
International Journal of Cancer|September 9, 2010
Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomasChien-Tsun Kuan, Kenji Wakiya, Stephen T Keir, et al.
Neuroepidemiology|January 24, 2004
Consistency of primary brain tumor diagnoses and codes in cancer surveillance systemsMonette S Castillo, Faith G Davis, Tanya Surawicz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 5, 2006
Exercise interest and preferences among patients diagnosed with primary brain cancerLee W Jones, Bebe Guill, Stephen T Keir, et al.
Psycho-Oncology|August 25, 2006
Using the theory of planned behavior to understand the determinants of exercise intention in patients diagnosed with primary brain cancerLee W Jones, Bebe Guill, Stephen T Keir, et al.
Plos One|January 10, 2019
Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumorsXin Yu, Mikhail Dobrikov, Stephen T Keir, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2011
Assessment of type of allergy and antihistamine use in the development of gliomaBridget J McCarthy, Kristin Rankin, Dora Il'yasova, et al.
Cancer Chemotherapy and Pharmacology|July 18, 2008
BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell lineManny D Bacolod, Randy Fehdrau, Stewart P Johnson, et al.
Expert Opinion on Therapeutic Targets|May 5, 2009
Glioblastoma multiforme: a review of therapeutic targetsOkezie O Kanu, Ankit Mehta, Chunhui Di, et al.
Pageof 25

Showing results (51-60 of 242) with videos related to

Sort By:
Pageof 25
Clinical Medicine. Oncology|September 25, 2009
Glioblastoma Multiforme Oncogenomics and Signaling PathwaysOkezie O Kanu, Betsy Hughes, Chunhui Di, et al.
Expert Opinion on Investigational Drugs|June 27, 2009
Glioblastoma multiforme: a review of where we have been and where we are goingCory Adamson, Okezie O Kanu, Ankit I Mehta, et al.
International Journal of Cancer|September 9, 2010
Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomasChien-Tsun Kuan, Kenji Wakiya, Stephen T Keir, et al.
Neuroepidemiology|January 24, 2004
Consistency of primary brain tumor diagnoses and codes in cancer surveillance systemsMonette S Castillo, Faith G Davis, Tanya Surawicz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 5, 2006
Exercise interest and preferences among patients diagnosed with primary brain cancerLee W Jones, Bebe Guill, Stephen T Keir, et al.
Psycho-Oncology|August 25, 2006
Using the theory of planned behavior to understand the determinants of exercise intention in patients diagnosed with primary brain cancerLee W Jones, Bebe Guill, Stephen T Keir, et al.
Plos One|January 10, 2019
Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumorsXin Yu, Mikhail Dobrikov, Stephen T Keir, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 9, 2011
Assessment of type of allergy and antihistamine use in the development of gliomaBridget J McCarthy, Kristin Rankin, Dora Il'yasova, et al.
Cancer Chemotherapy and Pharmacology|July 18, 2008
BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell lineManny D Bacolod, Randy Fehdrau, Stewart P Johnson, et al.
Expert Opinion on Therapeutic Targets|May 5, 2009
Glioblastoma multiforme: a review of therapeutic targetsOkezie O Kanu, Ankit Mehta, Chunhui Di, et al.
Pageof 25